Suzan Abou-Raya

Dr. Suzan Abou-Raya


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2009 in Age and Ageing
Verified
Journal Article
Open access
PDF file
SASuzan Abou-Raya
Suzan Abou-Raya
MHMadihah Helmii
Madihah Helmii
AAAnna Abou-Raya
Anna Abou-Raya
Objectives: Parkinson's disease (PD) and osteoporosis are two common chronic disabling conditions in older adults that adversely affect quality of life. The aim of the present work was to study the relationship between bone changes and PD. Methods: eighty-two patients with established PD aged 65 years or older and 68 age-, sex- and body mass index (BMI)-matched healthy control subjects were recruited. Exclusion criteria included other known causes of osteoporosis. Data including BMI, sunlight exposure, Hoehn and Yahr stage, disease duration and history of previous falls and/or fractures were collected. Bone mineral density was measured using dual energy x-ray absorptiometry. Sera were analysed for ionised calcium, vitamin D, bone alkaline phosphatase (BALP) and urinary N-terminal telopeptide of type I collagen (NTx). Physical and mental performance was also assessed. Results: the findings show that the bone mineral density (BMD) of all PD patients was significantly lower compared to controls. PD patients had significantly decreased vitamin D levels, significantly increased BALP and NTx levels, reduced physical and mental performance and more falls and/or fractures in comparison to healthy controls. Conclusion: PD is associated with an increased incidence of osteoporosis, falls and fractures. PD is thus a risk factor for osteoporosis and appropriate therapeutic interventions should be initiated to slow or prevent disability.

27 June 2012 in Age and Ageing
Verified
Journal Article
Open access
PDF file
SASuzan Abou-Raya
Suzan Abou-Raya
AAAnna Abou-Raya
Anna Abou-Raya
MHMadihah Helmii
Madihah Helmii
Pain is the leading symptom of osteoarthritis (OA) and is often chronic in nature, leading to significant morbidity and decreased quality of life. Duloxetine, a selective serotonin norepinephrine reuptake inhibitor has been demonstrated to have a centrally acting analgesic effect. the aim of the present study was to investigate the efficacy of duloxetine in reducing pain in older adults with knee OA. totally, 288 patients aged 65 years and above with primary knee OA were enrolled in this study. Patients were randomised 1:1. Totally, 144 received 60 mg/day of duloxetine HCL and 144 received placebo for 16 weeks. Outcome measures included pain reduction and improvement in physical functioning scores. Pain was assessed using the visual analogue pain scale (VAS; 0–100 mm). The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores were used to assess function. two-hundred and seventy four of the 288 patients completed the study. There was a statistically significant reduction in pain and a significant improvement in WOMAC scores at 16 weeks in the duloxetine group versus the placebo group. No serious side effects were reported. the findings of the present study provide evidence for the efficacy and tolerability of duloxetine in reducing pain and subsequently improving function in older adults with knee OA. NCT01425827.

17 August 2009 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
PDF file
SASuzan Abou-Raya
Suzan Abou-Raya
LELeila Abd ElMeguid
Leila Abd ElMeguid

1 September 2009 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
SASuzan Abou-Raya
Suzan Abou-Raya
AAAnna Abou-Raya
Anna Abou-Raya

1 August 2006 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
SASuzan Abou-Raya
Suzan Abou-Raya
AAA. Abou-Raya
A. Abou-Raya
The aim of the present study was to ascertain the degree of occurrence of tuberculous infection in patients presenting with low back pain (LBP).Forty consecutive patients seeking primary medical attention for the main symptom of LBP and presenting to the Rheumatology Outpatient Clinic of our institution from January 2004 to June 2005, were recruited in this cohort study. All patients were thoroughly interrogated (occupational, trauma, infection, diabetes mellitus and medication history), subjected to a rigorous clinical examination and a battery of investigationsTwelve of the 40 patients (33%) proved to have spinal TB as the cause of backache. Eight of these patients were above the age of 65. Five of the 12 patients with spinal TB also had concomitant osteoarthritic changes of the spine and two patients had concomitant disc prolapse. Eleven of the 12 patients with spinal TB had a completely normal chest X-ray and in 10 of these patients the plain X-ray of the lumbosacral region failed to show any significant lesion. In all 12 patients, sputum analysis failed to reveal acid-fast bacilli.The findings of this study indicate that TB is a common cause of LBP that is liable to be overlooked in the differential diagnosis of LBP. Furthermore, evidence of concurrent active intrathoracic TB may be lacking and consequently a high level of suspicion is required. The need for prompt diagnosis and treatment of skeletal TB is of utmost importance to prevent serious bone and joint destruction and severe neurological sequelae. A reliable imaging modality for diagnosing spinal TB seems to be magnetic resonance imaging.